↓ Skip to main content

The anticancer effects of HDAC inhibitors require the immune system

Overview of attention for article published in OncoImmunology, January 2014
Altmetric Badge

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The anticancer effects of HDAC inhibitors require the immune system
Published in
OncoImmunology, January 2014
DOI 10.4161/onci.27414
Pubmed ID
Authors

Alison C West, Mark J Smyth, Ricky W Johnstone

Abstract

Histone deacetylase inhibitors (HDACis) are known to exert immunomodulatory effects. We have recently demonstrated that the therapeutic efficacy of HDACis against aggressive B-cell lymphoma and colon carcinoma relies on a functional immune system, in particular on the production of interferon γ (IFNγ). Our findings provide a rationale for the combination of HDACis with immunotherapeutic agents in the clinic.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Israel 1 2%
United States 1 2%
Austria 1 2%
Unknown 55 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 20%
Researcher 11 19%
Other 7 12%
Student > Doctoral Student 6 10%
Student > Bachelor 5 8%
Other 11 19%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 16 27%
Biochemistry, Genetics and Molecular Biology 13 22%
Agricultural and Biological Sciences 6 10%
Immunology and Microbiology 5 8%
Chemistry 3 5%
Other 7 12%
Unknown 9 15%